site stats

Chimerix stock symbol

WebApr 6, 2024 · CHIMERIX, INC. Capi. / Sales 2024. Capi. / Sales 2024. Chimerix, Inc. is a biotechnology company. The Company is focused on developing medicines that address unmet medical needs. The Company's product Imipridones is a cancer therapy that provides ONC201, which is in clinical-stage development for H3 K27M-mutant glioma as its lead … WebGet the latest Chimerix Inc (CMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

CMRX - Chimerix Inc Forecast - CNNMoney.com

WebApr 11, 2024 · Chimerix (NASDAQ:CMRX) has a market capitalization of $105.92 million and generates $33.82 million in revenue each year. The biopharmaceutical company earns $172.17 million in net income (profit) … WebApr 6, 2024 · Get the latest news and real-time alerts from Chimerix, Inc. (CMRX) stock at Seeking Alpha. shank3 protein https://segnicreativi.com

Chimerix - CMRX - Stock Price Today - Zacks

WebFind the latest Institutional Holdings data for Chimerix, Inc. Common Stock (CMRX) at Nasdaq.com. Chimerix, Inc. Common Stock (CMRX) Institutional Holdings Nasdaq Skip to main content WebFeb 8, 2024 · Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute... WebChimerix, Inc. (CMRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Chimerix, Inc. (CMRX) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 1.2000 -0.0100... Find the latest Chimerix, Inc. (CMRX) stock discussion in Yahoo Finance's forum. … Chimerix, Inc. 2505 Meridian Parkway Suite 100 Durham, NC 27713 United States … Get the detailed quarterly/annual income statement for Chimerix, Inc. (CMRX). … Discover historical prices for CMRX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Chimerix, Inc. (CMRX), including valuation … See Chimerix, Inc. (CMRX) Environment, Social and Governance Ratings to help … See Chimerix, Inc. (CMRX) stock analyst estimates, including earnings and … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital … polymer alloy technology

CMRX - Chimerix, Inc. Stock Price and Quote - FINVIZ.com

Category:Chimerix, Inc. Common Stock (CMRX) Stock Price, Quote, …

Tags:Chimerix stock symbol

Chimerix stock symbol

CMRX Chimerix Inc. Stock Price & News - WSJ

WebApr 6, 2024 · Chimerix, Inc. is a biotechnology company. The Company is focused on developing medicines that address unmet medical needs. The Company's product Imipridones is a cancer therapy that provides ONC201, which is in clinical-stage development for H3 K27M-mutant glioma as its lead indication. WebChimerix Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... “Rubric”), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (“Chimerix” or the “Company”)...

Chimerix stock symbol

Did you know?

WebApr 10, 2024 · Chimerix Stock Price Today (NASDAQ: CMRX) Quote, Market Cap, Chart WallStreetZen Chimerix Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $1.22 -0.03 (-2.4%) Updated Mar 24, 2024 1W - 4.69% 1M - 20.78% 3M - 29.07% 1Y - 76.45% CMRX Price $1.22 Fair Value Price $1.51 Market Cap $107.69M … WebDiscover historical prices for CMRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Chimerix, Inc. stock was issued.

WebChimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner. Chimerix (CMRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a … WebApr 7, 2024 · Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute...

WebView the latest Chimerix Inc. (CMRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebMar 31, 2024 · Real Time Quote About Chimerix Inc. Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products.

WebFounders George Painter. Operating Status Active. Last Funding Type Grant. Legal Name Chimerix, Inc. Stock Symbol NASDAQ:CMRX. Company Type For Profit. Contact Email [email protected]. Phone Number 9193136782. Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including ...

WebWhat is the target price for Chimerix (CMRX) stock? The latest price target for Chimerix ( NASDAQ: CMRX) was reported by HC Wainwright & Co. on Friday, March 3, 2024. The analyst firm set a price ... shan kadavil net worthWebThe 6 analysts offering 12-month price forecasts for Chimerix Inc have a median target of 6.50, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +432.79% ... shanka han comercial eireliWebChimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 million, plus royalties. MarketWatch. 06:32AM. Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages. polymer analysis labWebMar 3, 2024 · Chimerix (CMRX) Stock Plummets 60% After Q1 Earnings Disappointment. By William White, InvestorPlace Writer May 16, 2024. Chimerix (CMRX) stock is falling hard on Monday following the release of ... shanka definitionWebMar 2, 2024 · Find the latest Earnings Report Date for Chimerix, Inc. Common Stock (CMRX) at Nasdaq.com. polymer airsoft gunsWebChimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC. polymer air preheaterWebFeb 17, 2024 · Every investor in Chimerix, Inc. (NASDAQ:CMRX) should be aware of the most powerful shareholder groups.We can see that institutions own the lion's share in the company with 53% ownership. In other ... shank agriculture